Pay in 4 interest-free payments of $5.15 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
SKBK, TM, FZ summarized the table and made the figures
Dinkla S, Peppelman M, Van Der Raadt J, Atsma F, Novotn VM, Van Kraaij MG, et al
Klaassen CD, et al
SGLT-2 inhibitors also modestly lower blood pressure (comparable to the introduction of a thiazide diuretic), reduce albuminuria and induce modest weight loss
Comparison of empagliflozin and glimepiride as add-on to metformin in patients with type 2 diabetes: a 104-week randomised, active-controlled, double-blind, phase 3 trial
Across diabetes and obesity, there are ~20 novel GLP-1 agonists and multi-agonists in Phase 2/3 development (see image 2) , with a host more in earlier stages
US$ 27.72
US$ 22.34
US$ 24.19
US$ 23.84
US$ 26.51
US$ 22.31
US$ 23.18
US$ 27.50
US$ 24.32
US$ 29.30
US$ 27.69
US$ 28.27
US$ 20.93
US$ 26.93
US$ 27.95
